News release

HP Showcases Life Sciences Contributions to Genetic Research and Drug Discovery

High-performance Computing and Software Partner Strategy Result in Speedy, Reliable and Cost-efficient Solutions

BOSTON, BioITWorld Conference & Expo, March 13, 2002

Hewlett-Packard Company (NYSE:HWP) is showcasing here the comprehensive hardware and software solutions it provides the life sciences market to accelerate drug discovery, better manage human genome information and enable collaborative research.

The solutions displayed include a representation of the more than 50 software applications available to genomics, bioinformatics, pharmaceutical, chemical and other life sciences companies, as well as to research institutions. Ranging in focus from research and development through clinical trials, the solutions support HP's strategy to become the life sciences industry's leading technical solutions partner.

"The life sciences industry needs fast workstations and servers, powerful systems and smart software to stay on the cutting edge," said David Valenta, global market development manager, HP Life Sciences. "HP has become the partner of choice for many life sciences software developers and customers. These relationships help us closely track industry advances to enable HP's products and services to meet current and future needs."

While other vendors seek entry points into this emerging industry, HP has been in the life sciences market since 1997 with solutions for computational chemists and molecular modelers. HP designs multi-purpose computers that can be configured to meet customers' specific needs and it provides a solid, scalable infrastructure with integrated solutions across hardware, software, servers, storage and networking.

HP is demonstrating at BioITWorld the results of its work with industry leaders and pioneers to deliver solutions that enable biotechnology and pharmaceutical companies to accelerate drug research and bring significant discoveries to market quickly and cost-efficiently. Solutions on exhibit include offerings from:

• Viaken -- a provider of discovery solutions, integrated research informatics platforms and collaborative research services to the pharmaceutical, biotechnology, agrochemical and other life science industries;

• Genomix Corp. -- a provider of analysis systems, information resources and partnering opportunities to guide research and development teams through critical steps in the pharmaceutical discovery and development processes; and

• Illumitek -- whose flagship product, nViZn, is a development platform for building embedded or standalone visual intelligence applications. HP and illumitek recently announced plans to incorporate in HP OpenView Dynamic Netvalue Analyzer technology illumitek's D3 platform, an enabling technology that integrates robust data mining, analysis, visualization and Web-based interactivity into one development platform.

HP also is providing demos of other HP products and services highlighting its comprehensive solutions, including HP Custom Software Solutions for security, porting and migration; RMSO, a business-to-employee portal solution that offers an interactive view of the @ HP Employee portal; and its Federated Storage Area Management (FSAM) strategy, a scalable storage plan that will be useful to life sciences companies in breaking through storage bottlenecks in today's new pharmaceutical development phase.

About HP

Hewlett-Packard Company -- a leading global provider of computing and imaging solutions and services -- is focused on making technology and its benefits accessible to all. HP had total revenue of $45.2 billion in its 2001 fiscal year. Information about HP and its products can be found on the World Wide Web at http://www.hp.com.

Intel is a U.S. registered trademark Itanium is a trademark of Intel Corporation in the U.S. and other countries and is used under license.

HP-UX Release 10.20 and later and HP-UX Release 11.00 and later (in both 32- and 64-bit configurations) on all HP 9000 computers are Open Group UNIX 95 branded products.

UNIX is a registered trademark of the Open Group. Microsoft and Windows are U.S. registered trademarks of Microsoft Corp.

This news release contains forward-looking statements that involve risks and uncertainties, as well as assumptions that, if they never materialize or prove incorrect, could cause the results of HP and its consolidated subsidiaries to differ materially from those expressed or implied by such forward-looking statements. All statements other than statements of historical fact are statements that could be deemed forward-looking statements, including any statements of the plans, strategies, and objectives of management for future operations; any statements concerting proposed new products, services, developments or industry rankings; any statements regarding future economic conditions or performance; statements of belief and any statement of assumptions underlying any of the foregoing. The risks, uncertainties and assumptions referred to above include the ability of HP to retain and motivate key employees; the timely development, production and acceptance of products and services and their feature sets; risks associated with customer uncertainty in light of proposed acquisitions; and other risks that are described from time to time in HP's Securities and Exchange Commission reports, including but not limited to the annual report on Form 10-K for the year ended Oct. 31, 2000, and subsequently filed reports. HP assumes no obligation and does not intend to update these forward-looking statements.